NASDAQ · Analyst Forecast

Sarepta Therapeutics, Inc. (SRPT) Stock Forecast & Price Target

$14.77 NASDAQ: SRPT Market Cap $1.58B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Sarepta Therapeutics, Inc. (SRPT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Sarepta Therapeutics, Inc., analysts forecast revenue falling from $1.86B in 2025 to $1.15B in 2030; the average estimate for 2030 earnings per share is −$0.74; with published estimates ranging from −$0.86 to −$0.58; 16 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$14.77
Consensus targetThe average of the price targets analysts have published.$21.40
Median targetThe middle target, less affected by a single outlier.$20.00
Highest targetThe most optimistic published target.$27.00
Lowest targetThe most pessimistic published target.$17.00
Difference from priceHow far the consensus target sits from today’s price.+44.9%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$1.84B$1.86B$1.88B15
2026$1.81B$1.87B$1.91B16
2027$1.22B$1.41B$1.63B16
2028$927.50M$1.35B$1.67B13
2029$1.01B$1.21B$1.37B11
2030$958.28M$1.15B$1.30B6

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$6.56−$4.89−$1.9415
2026$1.88$2.57$3.4516
2027$0.03$0.14$0.2716
2028−$1.04−$0.10$0.3313
2029−$0.76−$0.65−$0.5111
2030−$0.86−$0.74−$0.586

Sarepta Therapeutics, Inc. (SRPT) forecast — frequently asked questions

What is the analyst price target for Sarepta Therapeutics, Inc.?

Analysts covering Sarepta Therapeutics, Inc. (SRPT) have a consensus price target of $21.40, 44.9% above the current price of $14.77. Published targets range from $17.00 to $27.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Sarepta Therapeutics, Inc.'s earnings?

The average analyst estimate for Sarepta Therapeutics, Inc. (SRPT) earnings per share in 2030 is -0.74, with individual estimates between -0.86 and -0.58.

How much revenue is Sarepta Therapeutics, Inc. expected to make?

Analysts forecast Sarepta Therapeutics, Inc. (SRPT) revenue of $1.15B in 2030, based on 6 published estimates.

How many analysts cover SRPT?

16 analysts contribute estimates for Sarepta Therapeutics, Inc. (SRPT). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.